• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响人血浆低密度脂蛋白与载脂蛋白A-I和磷脂酰胆碱盘状复合物相互作用的因素。

Factors influencing interaction of human plasma low-density lipoproteins with discoidal complexes of apolipoprotein A-I and phosphatidylcholine.

作者信息

Shahrokh Z, Nichols A V

出版信息

Biochim Biophys Acta. 1986 Sep 12;878(2):152-8. doi: 10.1016/0005-2760(86)90141-4.

DOI:10.1016/0005-2760(86)90141-4
PMID:3092865
Abstract

The effect of plasma components on the particle size distribution and chemical composition of human plasma low-density lipoproteins (LDL) during interaction with discoidal complexes of human apolipoprotein A-I and phosphatidylcholine (PC) was investigated. Incubation (37 degrees C, 1 h and 6 h) of LDL with discoidal complexes in the presence of the plasma ultracentrifugal d greater than 1.20 g/ml fraction (activity of lecithin-cholesterol acyltransferase inhibited) produces an increase in LDL apparent particle diameter two-to six-fold greater than that observed in the absence of the plasma d greater than 1.20 g/ml fraction. In incubation mixtures of LDL and discoidal complexes, both in the presence and absence of the plasma d greater than 1.20 g/ml fraction, the extent of LDL apparent particle diameter increase is: (1) approximately three-fold greater at 6 h than at 1 h, and (2) markedly greater for LDL with initially small (22.4-24.0 nm) major components than for LDL with initially large (26.2-26.8 nm) major components. The facilitation factor in the plasma d greater than 1.20 g/ml fraction is not plasma phospholipid transfer protein. Purified human serum albumin produces an apparent particle diameter increase comparable to the plasma d greater than 1.20 g/ml fraction. The discoidal complex-induced increase in LDL apparent particle diameter value by albumin is associated with an increase in phospholipid uptake by LDL and a decreased loss of LDL unesterified cholesterol. In preliminary experiments, high-density lipoproteins (HDL) reverse the apparent particle diameter increase originally induced by discoidal complexes. The presence of HDL (HDL phospholipid/LDL phospholipid molar ratio of 10:1) in the incubation (6 h) mixture of LDL and discoidal complexes also attenuates LDL apparent particle diameter increase. In vivo, the plasma LDL/HDL ratio may be a controlling factor in determining the extent to which phospholipid uptake and the associated change in LDL particle size distribution occurs.

摘要

研究了血浆成分在与人载脂蛋白A-I和磷脂酰胆碱(PC)的盘状复合物相互作用期间对人血浆低密度脂蛋白(LDL)粒径分布和化学成分的影响。在血浆超速离心d大于1.20 g/ml组分存在的情况下(卵磷脂胆固醇酰基转移酶活性受到抑制),将LDL与盘状复合物一起孵育(37℃,1小时和6小时),LDL的表观粒径增加幅度比在没有血浆d大于1.20 g/ml组分的情况下观察到的增加幅度大两到六倍。在LDL和盘状复合物的孵育混合物中,无论是否存在血浆d大于1.20 g/ml组分,LDL表观粒径增加的程度为:(1)6小时时比1小时时大约大三倍;(2)对于最初主要成分粒径小(22.4 - 24.0 nm)的LDL,其增加幅度明显大于最初主要成分粒径大(26.2 - 26.8 nm)的LDL。血浆d大于1.20 g/ml组分中的促进因子不是血浆磷脂转运蛋白。纯化的人血清白蛋白产生的表观粒径增加与血浆d大于1.20 g/ml组分相当。白蛋白引起的盘状复合物诱导的LDL表观粒径值增加与LDL对磷脂摄取的增加以及LDL未酯化胆固醇损失的减少有关。在初步实验中,高密度脂蛋白(HDL)可逆转最初由盘状复合物诱导的表观粒径增加。在LDL和盘状复合物的孵育(6小时)混合物中存在HDL(HDL磷脂/LDL磷脂摩尔比为10:1)也会减弱LDL表观粒径的增加。在体内,血浆LDL/HDL比值可能是决定磷脂摄取程度以及LDL粒径分布相关变化的控制因素。

相似文献

1
Factors influencing interaction of human plasma low-density lipoproteins with discoidal complexes of apolipoprotein A-I and phosphatidylcholine.影响人血浆低密度脂蛋白与载脂蛋白A-I和磷脂酰胆碱盘状复合物相互作用的因素。
Biochim Biophys Acta. 1986 Sep 12;878(2):152-8. doi: 10.1016/0005-2760(86)90141-4.
2
Interaction of model discoidal complexes of phosphatidylcholine and apolipoprotein A-I with plasma components. Physical and chemical properties of the transformed complexes.磷脂酰胆碱和载脂蛋白A-I的模型盘状复合物与血浆成分的相互作用。转化复合物的物理和化学性质。
Biochim Biophys Acta. 1984 May 11;793(3):325-37. doi: 10.1016/0005-2760(84)90246-7.
3
Interaction of human-plasma low-density lipoproteins with discoidal complexes of apolipoprotein A-I and phosphatidylcholine, and characterization of the interaction products.人血浆低密度脂蛋白与载脂蛋白A-I和磷脂酰胆碱盘状复合物的相互作用及相互作用产物的表征
Biochim Biophys Acta. 1985 Dec 4;837(3):296-304. doi: 10.1016/0005-2760(85)90053-0.
4
Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.含载脂蛋白E的盘状复合物及其经卵磷脂胆固醇酰基转移酶的转化
Biochim Biophys Acta. 1989 Dec 18;1006(3):317-28. doi: 10.1016/0005-2760(89)90019-2.
5
Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: effects of plasma protein factors.重组高密度脂蛋白复合物与低密度脂蛋白之间的脂质转移:血浆蛋白因子的作用
J Lipid Res. 1988 Oct;29(10):1349-57.
6
Transformation of large discoidal complexes of apolipoprotein A-I and phosphatidylcholine by lecithin-cholesterol acyltransferase.卵磷脂胆固醇酰基转移酶对载脂蛋白A-I与磷脂酰胆碱的大型盘状复合物的转化作用。
Biochim Biophys Acta. 1988 Jul 1;961(1):73-85. doi: 10.1016/0005-2760(88)90132-4.
7
Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase.
Biochim Biophys Acta. 1985 May 17;834(3):285-300. doi: 10.1016/0005-2760(85)90001-3.
8
Increases in the particle size of high-density lipoproteins induced by purified lecithin: cholesterol acyltransferase: effect of low-density lipoproteins.纯化卵磷脂胆固醇酰基转移酶诱导的高密度脂蛋白粒径增加:低密度脂蛋白的影响
Biochim Biophys Acta. 1986 Jul 18;877(3):406-14. doi: 10.1016/0005-2760(86)90206-7.
9
Lecithin:cholesterol acyltransferase-induced transformation of HepG2 lipoproteins.卵磷脂:胆固醇酰基转移酶诱导的HepG2脂蛋白转化
J Lipid Res. 1989 Oct;30(10):1579-89.
10
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.在未酯化脂肪酸和载脂蛋白A-I来源存在的情况下,高密度脂蛋白前体与含载脂蛋白B的脂蛋白解离。
J Lipid Res. 1991 Jun;32(6):917-33.

引用本文的文献

1
Integrated Quantitative Targeted Lipidomics and Proteomics Reveal Unique Fingerprints of Multiple Metabolic Conditions.综合定量靶向脂质组学和蛋白质组学揭示多种代谢状况的独特特征。
Biomolecules. 2022 Oct 8;12(10):1439. doi: 10.3390/biom12101439.